mannose has been researched along with amphotericin b in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barwicz, J; Gruda, I; Rocheleau, H; Saint-Germain, G; Thérien, HM | 1 |
| Beloborodova, NV; Boĭko, NB; Demina, AM; Kurchavov, VA; Pozdorovkina, VV; Rogatina, EA | 1 |
| Ali, N; Veerareddy, PR; Vobalaboina, V | 1 |
| Dube, A; Dubey, V; Jain, NK; Mishra, D; Mishra, PK; Nahar, M | 1 |
| Jain, NK; Nahar, M | 1 |
| Gulbake, A; Jain, A; Jain, SK; Khare, P; Rathore, A; Shilpi, S | 1 |
| Mishra, PR; Singodia, D; Verma, A; Verma, RK | 1 |
| Jain, NK; Mehra, NK; Pruthi, J | 1 |
| Barros, D; Cordeiro-da-Silva, A; Costa Lima, SA | 1 |
| Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M | 1 |
| Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Ballesteros, MP; Bolás, F; Chauzy, A; de Pablo, E; Dea-Ayuela, MA; Fernández-García, R; Healy, AM; Kumar, D; Marchand, S; O'Connell, P; Serrano, DR; Tewes, F; Torrado, JJ | 1 |
12 other study(ies) available for mannose and amphotericin b
| Article | Year |
|---|---|
Modulation of amphotericin B activity by association with mannose ester.
Topics: Amphotericin B; Animals; Cell Division; Cell Line; Detergents; Hydrogen Peroxide; Macrophages, Peritoneal; Mannose; Mice; Mice, Inbred BALB C; Spectrophotometry | 1994 |
[Gas chromatography in express diagnosis of candidiasis and monitoring of antifungal therapy efficacy by D-arabinitol and mannose levels in pediatric patients].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Chromatography, Gas; Female; Fluconazole; Humans; Infant; Male; Mannose; Sugar Alcohols | 1998 |
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres.
Topics: Amphotericin B; Animals; Brain; Drug Carriers; Kidney; Leishmania donovani; Leishmaniasis; Liver; Mannose; Mice; Mice, Inbred BALB C; Nanospheres; Spleen; Tissue Distribution; Trypanocidal Agents | 2009 |
In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Carriers; Gelatin; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles | 2010 |
Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles.
Topics: Amphotericin B; Antiprotozoal Agents; Drug Delivery Systems; Flow Cytometry; Humans; Lactic Acid; Leishmania donovani; Macrophages; Mannose; Microscopy, Electron, Transmission; Molecular Structure; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2009 |
Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cations; Cricetinae; Female; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages; Male; Mannose; Mesocricetus; Molecular Structure | 2011 |
Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery.
Topics: Acetylglucosamine; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Lectins, C-Type; Leishmaniasis; Liposomes; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Particle Size; Rats; Rats, Wistar; Receptors, Cell Surface | 2012 |
Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes.
Topics: Amphotericin B; Animals; Drug Delivery Systems; Female; Hemolysis; Hydrogen-Ion Concentration; Kidney; Macrophages; Male; Mannose; Nanotubes, Carbon; Particle Size; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2012 |
Surface functionalization of polymeric nanospheres modulates macrophage activation: relevance in leishmaniasis therapy.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cells, Cultured; Cytokines; Drug Carriers; Lactic Acid; Leishmaniasis; Macrophage Activation; Macrophages; Male; Mannans; Mannose; Mice; Mice, Inbred BALB C; Nanospheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2015 |
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles | 2017 |
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution | 2018 |
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers.
Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Dry Powder Inhalers; Humans; Lung; Macrophages, Alveolar; Mannose; Particle Size; Pneumonia; Powders; Respiratory Aerosols and Droplets | 2023 |